Objective: Antiplatelet therapy is essential in neuroendovascular therapy to avoid periprocedual thromboembolic events. The purpose of our study was to evaluate the relationship between platelet aggregation analysis by VerifyNow assay system (Accumetrics, San Diego, CA, USA) and thromboembolic complications.
Methods: Seventy-two neuroendovascular procedures were performed between March 2013 and February 2015 in this instituion. There were 41 males (56.9%) and mean age was 69.9 years. Meanwhile, there were 31 females (43.0%) and mean age was 62.7 years. In all cases, clopidgrel (CLP) was used as one of the periprocedual antiplatelet therapy. All patients were measured CLP response as P2Y12 Reaction Units (PRU) value using VerifyNow assay system (Accumetrics, San Diego, CA, USA) with the whole blood sample collected from the long sheath located at the femoral artery. All patients received diffusion-weighted image (DWI) on MRI at 1-4 days after the procedure.
The occurrence of thromboembolic events was recorded and the relationship between CLP response and DWI hyper-intensity area (HIA) positive was analyzed. Appropriate cut-off value to predict thromboembolic events was examined.
Results: Symptomatic thromboembolic complications occur in 3 patients (4.1%), and each PRU value were all over 226. CLP hypo-responder in our study recognized 46 patients (63.8%) as cut-off PRU value set 208. As the result of cut-off value defined as CLP hypo-responder, with regard to PRU over 208, a significant difference appear in DWI HIA positive or negative, but with regard to PRU over 230, a significant difference is not recognized.
Conclusion: In our study, CLP response measured by VerifyNow assay system is well correlated with the periprocedual thromboembolic events in neuroendovascular procedure. The cut-off value of PRU i n neuroendovascular therapy is not still defined, but CLP hypo-responder defined PRU value over 208 might be meaningful in neuroendovascular therapy performed to Japanese. We should make the custom-made periprocedural anti-platelet therapy according to personal response.
and 112, FOV 220mm, matrix 160 X 136, 5.0mm/1.0mm, scan time 93sec) (Table 2) 
VerifyNow system で CLP hypo-responder と し て の cut-off 値 を PRU 208 説 明 : Hyper-intensity signal were seen at the motor hand cortex, and disorder of coordinated movement gradually appeared. 
